rs140332992

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP7BS2

This summary comes from the ClinGen Evidence Repository: The p.Arg31= variant in CDKL5 is present in 3 female and 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg31= variant is observed in at least 2 unaffected individuals (internal database) (BS2). The silent p.Arg31= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Arg31= variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP7). LINK:https://erepo.genome.network/evrepo/ui/classification/CA171658/MONDO:0100039/016

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000024 ( 0 hom. 9 hem. )

Consequence

CDKL5
NM_001323289.2 synonymous

Scores

2

Clinical Significance

Likely benign reviewed by expert panel U:2B:5

Conservation

PhyloP100: 0.862

Publications

1 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.93A>G p.Arg31Arg synonymous_variant Exon 3 of 18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.93A>G p.Arg31Arg synonymous_variant Exon 4 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.93A>G p.Arg31Arg synonymous_variant Exon 3 of 21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.93A>G p.Arg31Arg synonymous_variant Exon 3 of 18 1 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
AF:
0.0000448
AC:
5
AN:
111724
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000975
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000219
AC:
4
AN:
182437
AF XY:
0.0000298
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000237
AC:
25
AN:
1057042
Hom.:
0
Cov.:
24
AF XY:
0.0000274
AC XY:
9
AN XY:
328494
show subpopulations
African (AFR)
AF:
0.000234
AC:
6
AN:
25668
American (AMR)
AF:
0.0000285
AC:
1
AN:
35142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19097
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29986
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53145
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39971
Middle Eastern (MID)
AF:
0.000501
AC:
2
AN:
3996
European-Non Finnish (NFE)
AF:
0.0000199
AC:
16
AN:
805322
Other (OTH)
AF:
0.00
AC:
0
AN:
44715
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000447
AC:
5
AN:
111779
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33963
show subpopulations
African (AFR)
AF:
0.0000973
AC:
3
AN:
30836
American (AMR)
AF:
0.00
AC:
0
AN:
10473
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3560
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5979
Middle Eastern (MID)
AF:
0.00463
AC:
1
AN:
216
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53199
Other (OTH)
AF:
0.00
AC:
0
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Mar 10, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDKL5: BP4, BP7, BS2 -

Jun 19, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Aug 10, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CDKL5 disorder Benign:1
Sep 01, 2022
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

The p.Arg31= variant in CDKL5 is present in 3 female and 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg31= variant is observed in at least 2 unaffected individuals (internal database) (BS2). The silent p.Arg31= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Arg31= variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP7). -

History of neurodevelopmental disorder Benign:1
Jan 16, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico models in agreement (benign);Synonymous alterations with insufficient evidence to classify as benign -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Dec 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.9
DANN
Benign
0.75
PhyloP100
0.86
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140332992; hg19: chrX-18528968; API